Mallinckrodt, an Ireland-based drug company, has appointed Ray Furey as chief compliance officer.
Furey will join Mallinckrodt’s executive committee with dotted line reporting to the board of directors. He will report directly to Chief Executive Officer Mark Trudeau.
Furey joins Mallinckrodt after three years at Questcor, where he most recently was chief compliance officer. Before joining Questcor, Furey was corporate compliance officer at OSI Pharmaceuticals.